Core Insights - The company reported a revenue of 3.86 billion yuan for the first three quarters of 2025, representing a year-on-year increase of 21.05% [1] - The net profit attributable to shareholders for the same period was 333 million yuan, up 18.21% year-on-year [1] - In Q3 2025, the company achieved a revenue of 1.43 billion yuan, a year-on-year increase of 15.86%, but the net profit decreased by 6.64% to 130 million yuan [1] Brand Development - The domestic self-owned brands showed strong growth, with the launch of the Precision Nutrition series at the Asia Pet Expo in 2025, enhancing the product matrix [2] - The company collaborated with the national IP "Wulin Waizhuan" to expand its leading brand's reach [2] - The ZEAL brand introduced the New Zealand King Salmon series in Q3 2025, reinforcing its image of high-quality natural products [2] Financial Performance - The gross profit margin for Q3 2025 was 29.11%, an increase of 2.22 percentage points year-on-year, but a decrease of 1.86 percentage points quarter-on-quarter [2] - The net profit margin was 9.58%, down 2.39 percentage points year-on-year, but up 0.53 percentage points quarter-on-quarter [2] - Despite a complex external environment, the company maintained an overall profitability level that is considered excellent within the industry [2] Investment and Growth Strategy - The company increased its sales expenses to 462 million yuan, a year-on-year increase of 38.62%, and management expenses to 212 million yuan, up 59.44% [2] - Research and development expenses reached 73.63 million yuan, reflecting a year-on-year increase of 44.50% [2] - The company is committed to long-term development through increased investment in sales and R&D, enhancing the core competitiveness of its self-owned brands [2] Future Projections - The company is expected to achieve revenues of 5.34 billion yuan, 6.46 billion yuan, and 7.68 billion yuan for the years 2025 to 2027, respectively [3] - The projected net profits for the same period are 452 million yuan, 595 million yuan, and 711 million yuan [3] - Corresponding price-to-earnings ratios are forecasted to be 38.18, 28.97, and 24.27 times [3]